SCHEMBL1542358

SCHEMBL1542358

Cc1cc([N+](=O)[O-])c2nonc2c1NC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1L1 Q9UHC9 1/20 0.54
PTPN1 P18031 1/20 0.51
CYP17A1 P05093 5/20 0.49
MAPT P10636 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
KDM4E B2RXH2 2/20 0.49
ATIC P31939 1/20 0.45
LMNA P02545 5/20 0.42
CYP3A4 P08684 5/20 0.42
TSHR P16473 4/20 0.42
HSD17B10 Q99714 3/20 0.42
NR3C1 P04150 3/20 0.42
SHBG P04278 3/20 0.42
PGR P06401 3/20 0.42
SERPINA6 P08185 3/20 0.42
AR P10275 3/20 0.42
GPBAR1 Q8TDU6 3/20 0.42
SIGMAR1 Q99720 3/20 0.42
MAPK1 P28482 3/20 0.42
CYP19A1 P11511 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2448736 0.82 NPC1L1 (0.55) NPC1L1PTPN1CYP17A1MAPTSMN1; SMN2
SCHEMBL1542735 0.79 NPC1L1 (0.74) NPC1L1PTPN1CYP17A1MAPTSMN1; SMN2
4-Cholesten 3-One SCHEMBL20094570 0.76 NPC1L1 (0.79) NPC1L1PTPN1CYP17A1MAPTSMN1; SMN2
4-Cholesten 3-One SCHEMBL21176042 0.76 NPC1L1 (0.79) NPC1L1PTPN1CYP17A1MAPTSMN1; SMN2
4-Cholesten 3-One SCHEMBL19506686 0.76 NPC1L1 (0.79) NPC1L1PTPN1CYP17A1MAPTSMN1; SMN2
4-Cholesten 3-One SCHEMBL24151936 0.76 NPC1L1 (0.79) NPC1L1PTPN1CYP17A1MAPTSMN1; SMN2
4-Cholesten 3-One SCHEMBL2600424 0.76 NPC1L1 (0.79) NPC1L1PTPN1CYP17A1MAPTSMN1; SMN2
4-Cholesten 3-One SCHEMBL23452819 0.76 NPC1L1 (0.79) NPC1L1PTPN1CYP17A1MAPTSMN1; SMN2
4-Cholesten 3-One SCHEMBL10308280 0.76 NPC1L1 (0.79) NPC1L1PTPN1CYP17A1MAPTSMN1; SMN2
4-Cholesten 3-One SCHEMBL55896 0.76 NPC1L1 (0.79) NPC1L1PTPN1CYP17A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307438-B1 CHOLEST-4-EN-3-ONE OXIME DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND PREPARATION METHOD TROPHOS (FR) 2018-03-07 EP disclosed
EP-2307438-A2 NOVEL CHOLEST-4-EN-3-ONE OXIME DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND PREPARATION METHOD Trophos (FR) 2011-04-13 EP disclosed
WO-2010012904-A2 NOVEL CHOLEST-4-EN-3-ONE OXIME DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND PREPARATION METHOD TROPHOS (FR) 2010-02-04 WO disclosed